ArticleJournal of acquired immune deficiency syndromes (1999)2022

Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV/AIDS.

Max R O'Donnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.